- Home
- PBYI vs JOF Comparison
PBYI vs JOF Comparison
Compare PBYI & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | JOF |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.9M | 330.9M |
| IPO Year | 2011 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PBYI | JOF |
|---|---|---|
| Price | $8.07 | $11.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 374.7K | 70.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $9.52 |
| 52 Week High | $8.44 | $12.76 |
Technical Indicators
Market Signals| Indicator | PBYI | JOF |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 50.28 |
| Support Level | $6.50 | $11.27 |
| Resistance Level | $8.42 | $11.92 |
| Average True Range (ATR) | 0.41 | 0.23 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 47.13 | 35.71 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.